PO.CL01.03 · 临床研究

Urinary pesticide biomarkers and liver disease risk in Thailand: A machine-learning-based risk-prediction model

海报缩略图:Urinary pesticide biomarkers and liver disease risk in Thailand: A machine-learning-based risk-prediction model
编号 2443 展板 13 时间 4/20 09:00–12:00 区域 Section 40 主讲 Daxeshkumar Patel, PhD
分会场 Biomarkers Predictive of Therapeutic Benefit 3
查看完整资料 下载 PDF 登录后可访问当前开放资料 AACR 官方页面 ↗

作者与单位

Daxeshkumar P. Patel1, Christopher Loffredo2, Majda Haznadar3, Mohammed Khan4, Amelia Parker4, Benjarath Pupacdi5, Siritida Rabibhadana6, Panida Navasumrit7, Nirush Lertprasertsuke8, Anon Chotirosniramit9, Chawalit Pairojkul,10, Vor Luvira,11, Ake Pugkhem12, Wattana Sukeepaisarnjaroen12, Teerapat Ungtrakul13, Thaniya Sricharunrat14, Kannika Phornphutkul15, Frank J. Gonzalez16, Anuradha Budhu17, Chulabhorn Mahidol6, Xin Wei Wang18, Mathuros Ruchirawat7, Curtis C. Harris18, TIGER-LC Consortium

1LHC, CCR, NIH-NCI, Bethesda, MD,2Georgetown University, Washington, DC,3FDA, Silver Spring, MD,4Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA, Bethesda, MD,5Translational Research Unit, Chulabhorn Research Institute, Bangkok, Thailand,6Laboratory of Chemical Carcinogenesis, Chulabhorn Research Institute, Bangkok, Thailand,7Laboratory of Environmental Toxicology, Chulabhorn Research Institute, Bangkok, Thailand,8Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand,9Department of Surgery, Faculty of Medicine, Chiang Mai University,, Chiang Mai, Thailand,10Faculty of Medicine,, Khon Kaen University, Khon Kaen, Khon Kaen,, Thailand,11Khon Kaen University, Khon Kaen, Thailand;, Khon Kaen, Thailand,12Faculty of Medicine,, Khon Kaen University, Khon Kaen, Thailand;, Khon Kaen, Thailand,13Princess Srisavangavadhana Faculty of Medicine,, Chulabhorn Royal Academy, Bangkok, Thailand;, Bangkok, Thailand,14Princess Srisavangavadhana Faculty of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand,15Rajavej Hospital, Chiang Mai, Thailand,16Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD,17Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD,18National Cancer Institute, Bethesda, MD

摘要 Abstract

Background Building on evidence linking urinary glyphosate to chronic liver disease (CLD) and hepatocellular carcinoma (HCC), we developed urinary pesticide profiling integrated with machine learning risk prediction (MLRP) to stratify risk in high-exposure populations.Methods We conducted a case-control study within the Thailand Initiative in Genomics and Expression Research for Liver Cancer (TIGER-LC; 2011-2016; n=593): 228 CLD, 116 HCC, and 249 controls. Eight urinary pesticides were quantified by LC-MS/MS (pendimethalin, oxadiazon, metsulfuron-methyl, butachlor, 2,4-dichlorophenoxyacetic acid [2,4-D], cypermethrin, flocoumafen, bromadiolone). A composite Pesticide Load Score (PLS), with and without glyphosate, estimated burden. Two predictive models were developed: a logistic-regression Pesticide-Informed Liver Cancer Risk Score (PILCRS) and an Extreme Gradient Boosting (XGBoost) classifier that incorporated age, sex, alcohol use, occupation, and PLS. Internal validity used 1,000 bootstrap resamples with optimism-corrected calibration.Findings Predicted CLD probability increased from 30% in the lowest PLS quartile to over 70% in the highest, and HCC from 10% to 40% (p<0ꞏ0001). Relative estimates were consistent; the highest versus lowest quartile yielded odds ratios of 2ꞏ84 (95% CI 1ꞏ66-4ꞏ91) for CLD and 4ꞏ76 (2ꞏ30- 10ꞏ29) for HCC. Cypermethrin remained independently associated. After optimism correction, both models demonstrated strong discrimination and calibration.Interpretation This framework establishes a scalable, exposure-informed tool for liver disease prediction. Findings underscore pesticide burden as a modifiable risk factor and align with Sustainable Development Goal 3ꞏ9 and WHO-FAO priorities in low- and middle-income countries (LMICs). External validation is essential.
利益披露 Disclosure
D. P. Patel, None.. C. Pairojkul,, None.. V. Luvira,, None.. A. Pugkhem, None.. W. Sukeepaisarnjaroen, None.. T. Ungtrakul, None.

在会议检索中打开